NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/14/2018
Back to search
Official data from USPTO
BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS
ST13
US500000078920982Class
36
Filing
78920982
Registration
3379627
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
02/14/2018
Trademark type
Word
Nice classes
36
Filing date
06/30/2006
Registration date
02/05/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/14/2018
Last transaction
02/14/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/31/2006
First use in commerce
05/31/2006
Drawing code
4
Owner type
99
Owner location
Ann Arbor, MI, US
Examiner
MALIK, ATTIYA
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
T. F. (pessoa física)
Representatives
Paul R. Fransway Dickinson Wright, PLLC
Technical classification
Nice Classes
Class 36
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Charitable fundraising services for cancer research
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/14/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/14/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/14/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
01/25/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/24/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/05/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/30/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/30/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/30/2014
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
01/20/2014
E815
TEAS SECTION 8 & 15 RECEIVED
01/20/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/21/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/05/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/28/2007
ALIE
ASSIGNED TO LIE
12/27/2007
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/19/2007
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/06/2007
EX1G
SOU EXTENSION 1 GRANTED
12/06/2007
IUAF
USE AMENDMENT FILED
11/13/2007
EXT1
SOU EXTENSION 1 FILED
11/13/2007
EEXT
SOU TEAS EXTENSION RECEIVED
11/13/2007
EISU
TEAS STATEMENT OF USE RECEIVED
11/13/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/15/2007
PUBO
PUBLISHED FOR OPPOSITION
02/20/2007
NPUB
NOTICE OF PUBLICATION
01/31/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/08/2007
ALIE
ASSIGNED TO LIE
01/06/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2006
DOCK
ASSIGNED TO EXAMINER
12/01/2006
NWAP
NEW APPLICATION ENTERED
07/07/2006
Continuous trademark protection
Get notified about every new filing that threatens BECAUSE ANSWERS TO CANCERS COME FROM CLINICAL TRIALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.